HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oncogenic potential of the B-cell antigen receptor and its relevance to heavy chain diseases and other B-cell neoplasias: a new model.

Abstract
Some growth factor receptor genes can be activated to become oncogenic as a result of various mutations. The receptors that are encoded by these genes may deliver constitutive signals independent of ligand binding. The model which is presented here assumes that alterations in the B-cell antigen receptor could have similar effects. Evidence that membrane immunoglobulin alterations contribute to oncogenesis in vivo comes from studies of heavy chain diseases. Moreover, this model could have also implications for other B-cell neoplasias.
AuthorsD Corcos
JournalResearch in immunology (Res Immunol) 1990 Jul-Aug Vol. 141 Issue 6 Pg. 543-53 ISSN: 0923-2494 [Print] France
PMID2284498 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, Antigen, B-Cell
Topics
  • Gene Rearrangement, B-Lymphocyte
  • Heavy Chain Disease (etiology)
  • Humans
  • Models, Biological
  • Mutation
  • Neoplasms (etiology)
  • Oncogenes
  • Receptors, Antigen, B-Cell (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: